共 8 条
[1]
Baradelli L.B., Plosker G.L., McTavish D., Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with Acquired Immune Deficiency Syndrome, Drugs, 46, 2, pp. 289-312, (1993)
[2]
Dhillon J., Mitchison D.A., Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. Tuberculosis and their penetration into mouse peritoneal macrophages, Am Rev Respir Dis, 145, 21, (1992)
[3]
Mor N., Vanderkolk J., Heifets L., Accumulation of clarithromycin in macrophages infected with M. Avium, Pharmacotherapy, 14, 1, pp. 100-104, (1994)
[4]
Mor N., Heifets L., Inhibition of intracellular growth of M. Avium by one pulsed exposure of infected macrophages to clarithromycin, Antimicrob Agents Chemother, 37, pp. 1380-1382, (1993)
[5]
Acocella G., Carlone N.A., Cuffini A.M., Cavallo G., The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophage, Am Rev Respir Dis, 132, pp. 1268-1273
[6]
Easmon C., Crane J.P., Comparative uptake of rifampicin and rifapentine (DL473) by human neutrophils, J Antimicrob Chemother, 13, pp. 585-591, (1984)
[7]
Ishiguro M., Koga H., Kohno S., Hayashi T., Yamaguchi K., Hirota M., Penetration of macrolides into human polymorphonuclear leukocytes, J Antimicrob Chemother, 24, pp. 719-729, (1988)
[8]
Nibbering P.H., Zomerdisk T., Corsel-Van Tilberg A.J., Van Furth R., Mean cell volume of human blood leukocytes and resident and activated murine macrophages, J Immunol Meth, 129, pp. 143-145, (1990)